X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (13) 13
pharmacology & pharmacy (13) 13
animals (11) 11
histamine h2-receptor antagonist (11) 11
index medicus (10) 10
cimetidine (9) 9
male (9) 9
histamine h2 antagonists - pharmacology (7) 7
ranitidine (7) 7
rats (7) 7
drug interactions (6) 6
drug-interactions (6) 6
medicine & public health (6) 6
histamine h (5) 5
internal medicine (5) 5
pharmacology/toxicology (5) 5
pharmacotherapy (5) 5
receptor antagonist (5) 5
dose-response relationship, drug (4) 4
drug therapy (4) 4
famotidine (4) 4
female (4) 4
gastro-oesophageal-reflux (4) 4
gastrokinetics (4) 4
histamine h-2-receptor antagonist (4) 4
histamine h2 antagonists - therapeutic use (4) 4
histamine h2-receptor antagonists (4) 4
histamine-h2-receptor antagonist (4) 4
histamine-h2-receptor-antagonists (4) 4
lafutidine (4) 4
piperidines - pharmacology (4) 4
rats, sprague-dawley (4) 4
acetamides - pharmacology (3) 3
administration, oral (3) 3
anti-ulcer agents - pharmacology (3) 3
biochemistry & molecular biology (3) 3
chemistry, physical (3) 3
cimetidine - pharmacology (3) 3
complexes (3) 3
crystal-structure (3) 3
dosage and administration (3) 3
double-blind (3) 3
esomeprazole (3) 3
frg-8813 (3) 3
histamine (3) 3
histamine-h2-receptor antagonists (3) 3
histamine-h2-receptor-antagonists, drug interactio (3) 3
nonsteroidal antiinflammatory drugs (3) 3
omeprazole (3) 3
pharmacokinetics (3) 3
proton pump inhibitors (3) 3
proton-pump-inhibitors (3) 3
proton-pump-inhibitors, drug interactions (3) 3
pyridines - pharmacology (3) 3
research (3) 3
stomach ulcer - chemically induced (3) 3
stomach ulcer - drug therapy (3) 3
stomach ulcer - prevention & control (3) 3
acid (2) 2
adult (2) 2
aged (2) 2
analysis (2) 2
antacids (2) 2
antacids, therapeutic use (2) 2
anti-ulcer agents - administration & dosage (2) 2
anti-ulcer agents - adverse effects (2) 2
anti-ulcer agents - therapeutic use (2) 2
antiretrovirals, drug interactions (2) 2
c10h16n6s (2) 2
capsaicin - pharmacology (2) 2
cattle (2) 2
chemiluminescence (2) 2
chemistry, analytical (2) 2
children (2) 2
conformation (2) 2
dermatology (2) 2
diagnosis (2) 2
disease (2) 2
dogs (2) 2
domperidone (2) 2
enzyme inhibitors - pharmacology (2) 2
famotidine - pharmacology (2) 2
food (2) 2
gastric acid - secretion (2) 2
gastric mucosa - pathology (2) 2
gastric-secretion (2) 2
gastro-oesophageal-reflux, treatment (2) 2
gastroesophageal reflux (2) 2
gastroesophageal reflux - drug therapy (2) 2
gastrokinetics, therapeutic use (2) 2
gene-related peptide (2) 2
h-1-nmr (2) 2
h-2 receptors (2) 2
h-2-receptor antagonists (2) 2
histamine h2 antagonists - chemistry (2) 2
histamine-h2-receptor-antagonists, therapeutic use (2) 2
human plasma (2) 2
hydrogen (2) 2
in-vitro (2) 2
inhibition (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Pharmacokinetics, ISSN 0312-5963, 1/2011, Volume 50, Issue 1, pp. 25 - 39
Etravirine (formerly TMC125) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) with activity against wild-type and NNRTI-resistant strains of HIV-1.... 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Drug-interactions | Ribavirin, drug interactions | Antiepileptic-drugs, drug interactions | Simvastatin, drug interactions | Voriconazole, drug interactions | Dexamethasone, drug interactions | Fibric-acid-derivatives, drug interactions | Rifampicin, drug interactions | Opioid-analgesics, drug interactions | Antidepressants, drug interactions | Atorvastatin, drug interactions | Antiretrovirals, drug interactions | Anti-infectives, drug interactions | Histamine-H2-receptor-antagonists, drug interactions | Diazepam, drug interactions | Ketoconazole, drug interactions | Fluconazole, drug interactions | Hypericum, drug interactions | HMG-CoA-reductase-inhibitors, drug interactions | Oral-contraceptives, drug interactions | Sildenafil, drug interactions | Omeprazole, drug interactions | Buprenorphine, drug interactions | Rosuvastatin, drug interactions | Non-nucleoside-reverse-transcriptase-inhibitors, drug interactions | Type-5-cyclic-nucleotide- phosphodiesterase-inhibitors, drug interactions | Corticosteroids, drug interactions | Paroxetine, drug interactions | Fluoxetine, drug interactions | Rifapentine, drug interactions | Ethinylestradiolnorethisterone, drug interactions | Ranitidine, drug interactions | Etravirine, drug interactions | Antifungals, drug interactions | Digoxin, drug interactions | Warfarin, drug interactions | Methadone, drug interactions | Fluvastatin, drug interactions | Rifabutin, drug interactions | Sertraline, drug interactions | Azithromycin, drug interactions | Pharmacokinetics | Calcineurin-inhibitors, drug interactions | Itraconazole, drug interactions | Proton-pump-inhibitors, drug interactions | Clarithromycin, drug interactions | TRANSCRIPTASE INHIBITOR ETRAVIRINE | METABOLISM | EXPERIENCED HIV-1-INFECTED PATIENTS | TMC125 ETRAVIRINE | HIV-NEGATIVE VOLUNTEERS | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | HUMAN LIVER | PLACEBO-CONTROLLED TRIAL | 2 DIFFERENT FORMULATIONS | CLINICAL PHARMACOKINETICS | Reverse Transcriptase Inhibitors - adverse effects | Reverse Transcriptase Inhibitors - pharmacokinetics | Drug Interactions | Drug-Related Side Effects and Adverse Reactions | Humans | Pyridazines - pharmacokinetics | Drug Therapy, Combination | Pyridazines - adverse effects | Etravirine | Drug interactions | Physiological aspects | Dosage and administration | Research | Properties | Drug therapy | HIV infection
Journal Article
Journal Article
Advances in Therapy, ISSN 0741-238X, 10/2016, Volume 33, Issue 10, pp. 1704 - 1714
Journal Article
Clinical Pharmacokinetics, ISSN 0312-5963, 1991, Volume 21, Issue 3, pp. 178 - 194
Journal Article
Book Review
The Japanese Journal of Pharmacology, ISSN 0021-5198, 1997, Volume 73, Issue 3, pp. 229 - 241
We found indomethacin aggravates healed gastric ulcers (ulcer relapse)in rats. In the present study, we examined the effects of human basic fibroblast growth... 
TGP-580 | Basic fibroblast growth factor (bFGF) | bFGF mutein CS23 | Histamine H2-receptor antagonist | Gastric ulcer relapse | receptor antagonist | Histamine H | DUODENAL-ULCER | ACETIC-ACID ULCER | basic fibroblast growth factor (bFGF) | MECHANISMS | gastric ulcer relapse | LEUKOCYTE | THERAPY | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | ANTI-INFLAMMATORY DRUGS | DISEASE | PHARMACOLOGY & PHARMACY | ERADICATION | HELICOBACTER-PYLORI | histamine H-2-receptor antagonist | Cimetidine - therapeutic use | Immunohistochemistry | Recombinant Proteins - therapeutic use | Recurrence | Histamine H2 Antagonists - pharmacology | Fibroblast Growth Factor 2 - chemistry | Humans | Male | Fibroblast Growth Factors - analogs & derivatives | Indomethacin - administration & dosage | Histamine H2 Antagonists - administration & dosage | Drug Interactions | Acetic Acid - toxicity | Fibroblast Growth Factors - administration & dosage | Injections, Subcutaneous | Anti-Ulcer Agents - pharmacology | Cimetidine - administration & dosage | Stomach - drug effects | Ranitidine - pharmacology | Wound Healing - drug effects | Stomach Ulcer - prevention & control | Disease Models, Animal | Fibroblast Growth Factors - therapeutic use | Ranitidine - therapeutic use | Stomach Ulcer - chemically induced | Anti-Ulcer Agents - therapeutic use | Stomach - pathology | Administration, Oral | Stomach Ulcer - drug therapy | Acetic Acid - administration & dosage | Rats | Fibroblast Growth Factors - pharmacology | Recombinant Proteins - pharmacology | Histamine H2 Antagonists - therapeutic use | Rats, Sprague-Dawley | Anti-Inflammatory Agents, Non-Steroidal - toxicity | Recombinant Proteins - administration & dosage | Anti-Ulcer Agents - administration & dosage | Animals | Stomach - enzymology | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Cimetidine - pharmacology | Gastric Acid - metabolism | Ranitidine - administration & dosage | Indomethacin - toxicity | Peroxidase - metabolism
Journal Article
JOURNAL OF INORGANIC BIOCHEMISTRY, ISSN 0162-0134, 04/2002, Volume 89, Issue 3-4, pp. 237 - 247
Journal Article
World Journal of Gastroenterology, ISSN 1007-9327, 05/2006, Volume 12, Issue 18, pp. 3031 - 3037
AIM: Lafutidine, a histamine H-2 receptor antagonist, exhibits gastro-protective action mediated by capsaicin-sensitive afferent neurons (CSN). We compared the... 
Lafutidine | A histamine H | Prostaglandin | Capsaicin-sensitive afferent neuron | Gastric protection | TRPV1 | receptor antagonist | HISTAMINE H-2-RECEPTOR ANTAGONIST | GENE-RELATED PEPTIDE | prostaglandin | afferent neuron | RECEPTOR | MUCOSAL BLOOD-FLOW | a histamine H-2-receptor antagonist | HCO3-SECRETION | lafutidine | RAT STOMACH | gastric protection | capsaicin-sensitive | ION-CHANNEL | CYTOPROTECTION | MICE | SENSORY NERVES | GASTROENTEROLOGY & HEPATOLOGY | Dinoprostone - analysis | Stomach - chemistry | Capsaicin - pharmacology | Histamine H2 Antagonists - pharmacology | Humans | Stomach Diseases - chemically induced | Acetamides - pharmacology | Gastric Mucosa - pathology | Male | Stomach Diseases - pathology | Calcium - analysis | 6-Ketoprostaglandin F1 alpha - analysis | Dose-Response Relationship, Drug | Piperidines - pharmacology | TRPV Cation Channels - antagonists & inhibitors | Receptors, Epoprostenol - physiology | Stomach Diseases - prevention & control | Stomach - drug effects | Gastric Mucosa - chemistry | NG-Nitroarginine Methyl Ester - pharmacology | Neurons, Afferent - drug effects | TRPV Cation Channels - physiology | Mice, Inbred C57BL | Rats | Capsaicin - analogs & derivatives | Neurons, Afferent - physiology | Rats, Sprague-Dawley | Indomethacin - pharmacology | Mice, Knockout | Prostaglandins - physiology | Receptors, Epoprostenol - genetics | Animals | Mice | Pyridines - pharmacology | A histamine H2-receptor antagonist | Basic Research
Journal Article
Journal Article
Drug metabolism and drug interactions, ISSN 0792-5077, 1995, Volume 12, Issue 1, pp. 1 - 36
Journal Article
JAPANESE JOURNAL OF PHARMACOLOGY, ISSN 0021-5198, 09/1991, Volume 57, Issue 1, pp. 13 - 23
3-Amino-4-[4-[4-(1-piperidinomethyl)-2-pyridyloxy]-cis-2-butenylamino]-3-cyclobutene-1,2-dione hydrochloride (IT-066) showed a highly potent and long lasting... 
DRUG RECEPTORS | INHIBITION | DOGS | HISTAMINE H2-RECEPTOR ANTAGONISTS | PHARMACOLOGY & PHARMACY | GASTRIC-ACID SECRETION | YM-11170
Journal Article
by
Drugs & Therapy Perspectives, ISSN 1172-0360, 7/2012, Volume 28, Issue 7, pp. 14 - 16
  Proton pump inhibitors (PPIs) remain the cornerstone of gastro-oesophageal reflux disease (GORD) management. However, the limitations of PPIs and emerging... 
Pharmacotherapy | Pharmacy | Domperidone | Proton-pump-inhibitors | Surgery | Baclofen | Therapeutic-procedures | Acupuncture | Gastro-oesophageal-reflux | Histamine-H2-receptor-antagonists | Metoclopramide | Gastrokinetics | Gastroesophageal reflux | Proton pump inhibitors | Dosage and administration | Drug therapy
Journal Article
Journal Article